Serological assays for the diagnosis and management of inflammatory bowel disease: crohn's disease
Record ID 32013000304
English
Authors' recommendations:
Inflammatory bowel disease (IBD) is associated with a serological response, the production of particular antibodies, to various microbial antigens and auto-antigens in the gastrointestinal tract. Serological assays, particularly enzyme-linked immunosorbent assays (ELISAs) and indirect immunofluorescence assays (IFAs), are used to identify the presence of particular antibodies in blood samples from patients with ulcerative colitis (UC) or Crohn's disease (CD), the two forms of IBD. The goal of this strategy is to identify antibodies that may serve as markers for UC or CD, which may be used to improve the diagnosis and management of these disorders.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
The report may be purchased from: http://www.hayesinc.com/hayes/crd/?crd=2331
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Serologic Tests
- Inflammatory Bowel Diseases
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2013 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.